BAYN.DE
XETRABayer AG
Healthcare · Drug Manufacturers - General
Einschätzung
Signal vor 2 Std.Kein kaufbarer Dip: 3.5 % unter dem 30-Tage-Hoch. Hier gibt es nichts zu tun.
Katalysatoren
vor 3 Std.- Nachrichten, letzte 10 Tage
- positiv +0.435 Artikel
- Nächste Zahlen
- 3.11.2026 · in 47 Tagen
- Letzter Bericht
- 31.7.2026 +27.3% vs. Schätzung
Handelsmarken
Warum die Engine so urteilt
Verlauf für diesen Ticker
Beobachten und Alarm
Über Bayer AG
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- Sitz:
- Leverkusen, Germany
- 52-Wochen-Spanne:
- €25.78 – €53.92
- Website:
- bayer.com
Signale entstehen automatisch aus Kurs, Volumen und technischen Indikatoren. Sie sind keine Anlageberatung.← Zurück zur Suche